Media Center

Today, the House Judiciary Committee passed H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, by a vote of 24-10. The MORE Act is one of the most comprehensive marijuana reforms bills ever introduced in the U.S. Congress.

Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019:

"H.R. 3884, the 'Marijuana Opportunity Reinvestment and Expungement Act of 2019,' or the 'MORE Act of 2019.' This bill would make three important changes to federal law. It would:

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019:

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a markup of H.R. 5038, the Farm Workforce Modernization Act of 2019:

"With today's markup, the House Judiciary Committee is taking an important step towards finally addressing an issue of critical national importance: the growing labor challenges on America's farms.

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 5133, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019:

Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the Subcommittee on Courts, Intellectual Property, and the Internet hearing on "The Patent Trial and Appeal Board and the Appointments Clause: Implications of Recent Court Decisions":

Yesterday, the Trump Administration published two notices in the federal register which would implement the "Asylum Cooperative Agreement" or "Safe Third Country Agreement" signed with Guatemala in July. In response, Jerrold Nadler, Chair of the House Committee on the Judiciary, and Zoe Lofgren, Chair of the Subcommittee on Immigration and Citizenship, released the following statement:

Today, House Antitrust Subcommittee Chair David N. Cicilline (RI-01) and Judiciary Committee Chairman Jerrold Nadler (NY-10) introduced The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 (H.R. 5133) to prohibit pharmaceutical companies from engaging in anticompetitive "product hopping." The bill is scheduled to be marked up in the Judiciary Committee on Wednesday.